Sequenom Company Profile (NASDAQ:SQNM)

About Sequenom

Sequenom logoSequenom, Inc. is a life sciences company. The Company serves patients and physicians by providing early patient management information. The Company operates through Sequenom Laboratories segment. It conducts its business as a molecular diagnostics clinical laboratory located in San Diego, California and Raleigh-Durham, North Carolina. Its testing focus is on prenatal health that includes molecular-based laboratory developed tests (LDTs). The Company's diagnostic services are provided through its subsidiary, Sequenom Center for Molecular Medicine LLC (SCMM), doing business as Sequenom Laboratories. Sequenom Laboratories develops and validates its tests to be used as a testing service to physicians. Sequenom Laboratories is focused on developing and offering a menu of tests for prenatal continuum of care. The Sequenom Laboratories' test offerings in the prenatal market include MaterniT21 PLUS LDT, HerediT CF test, SensiGene RhD test, VisibiliT test and Test Send-out Agreements.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: SQNM
  • CUSIP: 81733740
Key Metrics:
  • Previous Close: $2.39
  • 50 Day Moving Average: $2.16
  • 200 Day Moving Average: $1.47
  • 52-Week Range: $0.82 - $2.53
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -18.38
  • P/E Growth: 0.00
  • Market Cap: $N/A
  • Beta: 1.17
  • Net Margins: -36.10%
  • Return on Assets: -35.58%
  • Debt-to-Equity Ratio: -2.35%
  • Current Ratio: 3.35%
  • Quick Ratio: 3.16%
Additional Links:
Companies Related to Sequenom:

Analyst Ratings

Consensus Ratings for Sequenom (NASDAQ:SQNM) (?)
Ratings Breakdown: 5 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $1.45 (39.33% downside)

Analysts' Ratings History for Sequenom (NASDAQ:SQNM)
DateFirmActionRatingPrice TargetDetails
7/20/2016Jefferies GroupReiterated RatingHold$1.50 -> $0.75View Rating Details
6/29/2016William BlairReiterated RatingMarket PerformView Rating Details
3/3/2016Piper Jaffray Cos.Reiterated RatingHold$2.10View Rating Details
3/3/2016Ladenburg ThalmannUpgradeSell -> NeutralView Rating Details
11/25/2015WedbushReiterated RatingNeutral$1.50View Rating Details
5/8/2015Oppenheimer Holdings Inc.Reiterated RatingOutperform -> BuyView Rating Details
(Data available from 10/28/2014 forward)


Earnings History for Sequenom (NASDAQ:SQNM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/5/2016Q216($0.09)($0.05)$28.65 millionViewN/AView Earnings Details
5/4/2016Q116($0.10)($0.11)$27.85 million$27.57 millionViewN/AView Earnings Details
3/2/2016Q415($0.10)($0.10)$29.35 million$27.80 millionViewN/AView Earnings Details
11/4/2015Q315($0.09)($0.08)$31.35 million$29.90 millionViewN/AView Earnings Details
8/5/2015Q215($0.05)($0.08)$35.74 million$32.77 millionViewN/AView Earnings Details
5/6/2015Q115($0.03)$0.12$38.60 million$37.80 millionViewN/AView Earnings Details
3/4/2015Q414($0.05)$0.14$41.94 million$36.80 millionViewN/AView Earnings Details
11/4/2014Q314($0.09)($0.05)$42.80 million$37.90 millionViewN/AView Earnings Details
7/29/2014Q214($0.10)($0.07)$47.80 million$39.80 millionViewN/AView Earnings Details
5/1/2014Q114($0.14)($0.13)$46.06 million$46.30 millionViewN/AView Earnings Details
2/27/2014Q413($0.16)($0.16)$47.05 million$45.13 millionViewN/AView Earnings Details
11/7/2013Q313($0.22)($0.24)$40.56 million$43.90 millionViewN/AView Earnings Details
7/24/2013Q2 2013($0.22)($0.27)$46.25 million$24.50 millionViewN/AView Earnings Details
5/9/2013Q1 2013($0.23)($0.26)$38.29 million$38.50 millionViewN/AView Earnings Details
3/7/2013Q4 2012($0.22)($0.29)$32.02 million$33.67 millionViewN/AView Earnings Details
11/8/2012Q312($0.23)($0.26)$22.91 million$22.90 millionViewN/AView Earnings Details
7/26/2012($0.21)($0.26)ViewN/AView Earnings Details
5/3/2012($0.19)($0.22)ViewN/AView Earnings Details
3/7/2012($0.18)($0.22)ViewN/AView Earnings Details
11/3/2011($0.19)($0.19)ViewN/AView Earnings Details
8/4/2011($0.17)($0.21)ViewN/AView Earnings Details
5/5/2011($0.19)($0.13)ViewN/AView Earnings Details
3/8/2011($0.21)($0.27)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Sequenom (NASDAQ:SQNM)
Current Year EPS Consensus Estimate: $-0.30 EPS
Next Year EPS Consensus Estimate: $-0.13 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.11)($0.09)($0.10)
Q2 20161($0.10)($0.10)($0.10)
Q3 20161($0.06)($0.06)($0.06)
Q4 20162($0.09)($0.05)($0.07)
Q1 20171($0.04)($0.04)($0.04)
Q2 20171($0.04)($0.04)($0.04)
Q3 20171($0.03)($0.03)($0.03)
Q4 20171($0.03)($0.03)($0.03)
(Data provided by Zacks Investment Research)


Dividend History for Sequenom (NASDAQ:SQNM)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Sequenom (NASDAQ:SQNM)
Insider Ownership Percentage: 3.10%
Institutional Ownership Percentage: 46.03%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/7/2016Corp Of America Hol LaboratoryMajor ShareholderBuy36,649,440$2.40$87,958,656.00View SEC Filing  
6/10/2016Carolyn BeaverCFOBuy30,000$1.10$33,000.00View SEC Filing  
6/9/2016Carolyn BeaverCFOBuy10,000$1.10$11,000.00View SEC Filing  
6/9/2016Jeffrey D LintonSVPBuy5,000$1.10$5,500.00View SEC Filing  
6/8/2016Den Boom Dirk VanCEOBuy40,000$1.09$43,600.00View SEC Filing  
5/11/2016Daniel S Md GrosuCMOBuy30,000$1.11$33,300.00View SEC Filing  
5/6/2016Den Boom Dirk VanCEOBuy30,000$1.13$33,900.00View SEC Filing  
5/6/2016Jeffrey D LintonSVPBuy10,000$1.15$11,500.00View SEC Filing  
1/4/2016Camber Capital Management LlcMajor ShareholderBuy665,435$1.62$1,078,004.70View SEC Filing  
12/16/2015Camber Capital Management LlcMajor ShareholderBuy468,000$1.30$608,400.00View SEC Filing  
12/15/2015Camber Capital Management LlcMajor ShareholderBuy20,000$1.41$28,200.00View SEC Filing  
12/14/2015Camber Capital Management LlcMajor ShareholderBuy448,000$1.30$582,400.00View SEC Filing  
12/10/2015Camber Capital Management LlcMajor ShareholderBuy791,565$1.30$1,029,034.50View SEC Filing  
10/8/2015Camber Capital Management LlcMajor ShareholderBuy1,650,090$1.96$3,234,176.40View SEC Filing  
3/10/2015William J WelchCEOBuy10,000$3.65$36,500.00View SEC Filing  
3/9/2015Carolyn BeaverCFOBuy10,000$3.60$36,000.00View SEC Filing  
3/6/2015Jeffrey D LintonSVPBuy10,000$3.64$36,400.00View SEC Filing  
11/29/2012Goldman Myla LaiDirectorBuy4,000$4.59$18,360.00View SEC Filing  
11/26/2012John A FazioDirectorBuy2,000$4.45$8,900.00View SEC Filing  
8/8/2012Charles P SlacikDirectorBuy5,000$3.24$16,200.00View SEC Filing  
8/7/2012John A FazioDirectorBuy2,000$3.33$6,660.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Sequenom (NASDAQ:SQNM)
News IconUpgrades And Downgrades For Sequenom, Inc. (NASDAQ:SQNM) - NewsDen (NASDAQ:SQNM) - October 27 at 12:34 PM
News IconConsensus Notes on Sequenom, Inc. (NASDAQ:SQNM) - AR News (NASDAQ:SQNM) - October 26 at 11:03 AM
News IconStock Update on Earnings & Estimates for Sequenom, Inc. (NASDAQ:SQNM) - CSZ News (NASDAQ:SQNM) - October 22 at 11:28 AM
News IconSequenom, Inc. (NASDAQ:SQNM) Updated Broker Price Targets - The De Soto Edge (NASDAQ:SQNM) - October 21 at 7:28 PM
News IconInvestor Alert: Sequenom, Inc. (NASDAQ:SQNM) Price Target Update - Recall News (NASDAQ:SQNM) - October 18 at 12:25 PM logoLabCorp Subsidiary Sequenom, Inc. Announces Expiration of and Final Tender Results for Tender Offers for 5% Convertible Senior Notes Due 2017 and 5% Convertible Senior Exchange Notes Due 2018 (NASDAQ:SQNM) - October 18 at 12:24 PM
News IconLooking Ahead for Sequenom, Inc. (NASDAQ:SQNM); Are These Shares Ready to Go Higher? - CSZ News (NASDAQ:SQNM) - October 14 at 7:14 PM logoState clawing back $1.36M in grant incentives (NASDAQ:SQNM) - October 11 at 8:16 PM
News IconSell-side Taking Aim at Shares of Sequenom, Inc. (NASDAQ:SQNM) - Frisco Fastball (NASDAQ:SQNM) - September 30 at 12:41 PM
News IconStock Update: Estimates & Target in Focus for Sequenom, Inc ... - Frisco Fastball (NASDAQ:SQNM) - September 23 at 11:37 AM logoFundamental Change Notice Related to Sequenom, Inc. 5.00% Convertible Senior Notes Due 2017 and 5.00% Convertible Exchange Senior Notes Due 2018. (NASDAQ:SQNM) - September 16 at 7:09 PM logoBRIEF-Sequenom announces tender offers, consent solicitations for 5 pct convertible senior notes (NASDAQ:SQNM) - September 16 at 2:24 PM
News IconStock Update, a Closer Look at Sequenom Inc. (NASDAQ:SQNM) - Duncan Research (NASDAQ:SQNM) - September 15 at 11:07 AM
News IconMaking News: Targeting shares of Sequenom Inc. (NASDAQ:SQNM) - Duncan Research (NASDAQ:SQNM) - September 9 at 7:03 PM
News IconBiotech Stocks To Put On Your Watch List: Sequenom Inc. (NASDAQ:SQNM), Keryx Biopharmaceuticals Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:SQNM) - September 9 at 7:03 PM
News IconAnalysts Valuations For Two Stocks: Sequenom, Inc. (NASDAQ:SQNM), Legg Mason Inc (NYSE:LM) - The Voice Registrar (NASDAQ:SQNM) - September 9 at 7:03 PM logoFaruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against Sequenom, Inc. (NASDAQ:SQNM) - September 7 at 7:34 PM logoSEQUENOM INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition (NASDAQ:SQNM) - September 7 at 7:34 PM logoLaboratory Corporation of America® Holdings Successfully Completes Acquisition of Sequenom, Inc. (NASDAQ:SQNM) - September 7 at 11:09 AM
News IconHC Stocks Reports- Idera Pharmaceuticals Inc (IDRA), Sequenom, Inc. (NASDAQ:SQNM) - share market updates (press release) (NASDAQ:SQNM) - September 6 at 11:41 AM
News IconHot Biotech Stocks Recap: Sequenom Inc. (NASDAQ:SQNM), Seattle Genetics, Inc. (NASDAQ:SGEN) - The Voice Registrar (NASDAQ:SQNM) - September 6 at 11:41 AM logoSequenom, Inc. (NASDAQ:SQNM) Is Expected To Post EPS Of $-0.03 - (NASDAQ:SQNM) - September 2 at 7:20 PM
News IconInvestor News: Lawsuit against Takeover of Sequenom, Inc. (NASDAQ:SQNM) - GroundReport (NASDAQ:SQNM) - September 2 at 7:20 PM logoETF’s with exposure to Sequenom, Inc. : September 1, 2016 (NASDAQ:SQNM) - September 1 at 10:39 AM
News IconSequenom Inc.'s (SQNM): Look closely Shares - Hot Stocks Point (NASDAQ:SQNM) - August 30 at 10:47 AM logoLawsuit for Investors in Effort to Halt Takeover of Sequenom, Inc. (NASDAQ:SQNM) Filed (NASDAQ:SQNM) - August 26 at 10:28 AM
News IconTechnical Analysis on Overbuying: Sequenom, Inc. (NASDAQ:SQNM) - Post Registrar (NASDAQ:SQNM) - August 25 at 12:01 PM logoBRIEF-Labcorp's acquisition of Sequenom clears antitrust review (NASDAQ:SQNM) - August 23 at 9:41 AM
News IconStocks on the Move: Immune Pharmaceuticals Inc (NASDAQ:IMNP ... - Post Registrar (NASDAQ:SQNM) - August 22 at 7:26 PM logoGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Sequenom, Inc. (SQNM) (NASDAQ:SQNM) - August 22 at 7:26 PM
News IconSmall Cap Insight on Shares of Sequenom Inc. (NASDAQ:SQNM) - Duncan Research (NASDAQ:SQNM) - August 20 at 7:05 PM
News IconInvestor News: Buyout of Sequenom, Inc. (NASDAQ:SQNM) under Investigation - GroundReport (NASDAQ:SQNM) - August 20 at 7:05 PM
News IconBiotech Stocks Worth a Closer Look: Relypsa (NASDAQ:RLYP), Sequenom (NASDAQ:SQNM) - The Voice Registrar (NASDAQ:SQNM) - August 20 at 7:05 PM logoWill Sequenom, Inc. (NASDAQ:SQNM) Hit $2.4 Price Target? - Investor Newswire (NASDAQ:SQNM) - August 20 at 7:05 PM
News IconActive biotech company shares in the news: Sequenom Inc ... - The Voice Registrar (NASDAQ:SQNM) - August 17 at 7:54 PM
News IconThe Statistics Don't Lie: Sequenom Inc. (NASDAQ:SQNM) Earnings ... - The Voice Registrar (NASDAQ:SQNM) - August 16 at 7:40 PM logoSEQUENOM INC Financials (NASDAQ:SQNM) - August 13 at 7:06 PM logoETF’s with exposure to Sequenom, Inc. : August 12, 2016 (NASDAQ:SQNM) - August 12 at 7:41 PM logoSequenom, Inc. :SQNM-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 (NASDAQ:SQNM) - August 11 at 8:06 PM logoLabCorp Begins Cash Tender Offer For Sequenom Shares - Quick Facts (NASDAQ:SQNM) - August 9 at 7:52 PM logoSequenom: The Last Chapter Is A Head Scratcher - Seeking Alpha (NASDAQ:SQNM) - August 8 at 12:19 PM logoSEQUENOM INC Files SEC form 10-Q, Quarterly Report (NASDAQ:SQNM) - August 5 at 7:47 PM logoAnalyst Ratings Summary To Observe: Sequenom, Inc. (NASDAQ:SQNM), Pattern Energy Group Inc (NASDAQ:PEGI) - Review Fortune (NASDAQ:SQNM) - August 3 at 7:55 PM logoQ2 2016 Sequenom Inc Earnings Release - After Market Close (NASDAQ:SQNM) - August 3 at 10:48 AM logoTraders Recap: Sequenom Inc. (SQNM), HollyFrontier Corporation ... - iStreetWire (NASDAQ:SQNM) - August 2 at 7:54 PM
News IconHC Stocks Summary: Sequenom, Inc. (NASDAQ:SQNM) Relypsa Inc (NASDAQ:RLYP) - share market updates (press release) (NASDAQ:SQNM) - August 2 at 12:29 PM logoSEQUENOM SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Sequenom, Inc. (SQNM) … (NASDAQ:SQNM) - August 1 at 7:19 PM logoSEQUENOM SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Sequenom, Inc. (SQNM) Over the Proposed Sale of the Company to Laboratory Corporation of America Holdings (NASDAQ:SQNM) - August 1 at 7:19 PM
News IconInvestigation for Investors over Potential Wrongdoing in Buyout of Sequenom, Inc. (NASDAQ:SQNM) Announced (NASDAQ:SQNM) - August 1 at 12:10 PM logoLabCorp Takes Sequenom For $300m - Sequenom, Inc. (NASDAQ ... - Seeking Alpha (NASDAQ:SQNM) - July 29 at 7:43 PM


Sequenom (NASDAQ:SQNM) Chart for Friday, October, 28, 2016

Last Updated on 10/28/2016 by Staff